Home ›
Trademark Categories ›
Pharmaceuticals ›
1999 ›
AT ›
ATACAND PLUS
Trademark search for:
ATACAND PLUS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2003-02-25 — Application filed
2003-08-14 — Final disposition recorded
2003-08-14 — Assigned to examiner
2004-02-17 — Correspondence received in law office
2004-02-19 — Paper received
2004-03-26 — Teas change of correspondence received
2005-04-22 — Office action issued
2005-04-22 — Office action issued
2005-06-09 — Paper received
2005-06-09 — Correspondence received in law office
2005-06-17 — Amendment from applicant entered
2005-06-20 — Approved for pub - principal register
2005-06-24 — Assigned to lie
2005-07-01 — Law office publication review completed
2005-09-20 — Withdrawn from pub - og review query
2005-10-04 — Previous allowance count withdrawn
2005-10-18 — Final disposition recorded
2005-10-18 — Correspondence e-mailed
2006-03-29 — Examiners amendment -written
2006-03-29 — Approved for pub - principal register
2006-03-29 — Examiners amendment e-mailed
2006-03-29 — Examiner's amendment entered
2006-03-31 — Assigned to lie
2006-06-01 — Teas change of correspondence received
2006-06-01 — Teas change of correspondence received
2006-06-02 — Teas change of correspondence received
2006-07-24 — Assigned to lie
2006-07-26 — Law office publication review completed
2006-08-30 — Notice of publication
2006-09-19 — Published for opposition
2006-12-12 — Noa mailed - sou required from applicant
2007-06-13 — Final status recorded
2007-07-23 — Attorney/dom.rep.revoked and/or appointed
2007-07-23 — Teas revoke/app/change addr of atty/dom rep received
2007-12-06 — Application abandoned
2007-12-10 — Application abandoned
Owner Information
AstraZeneca AB
Sodertalje SE
AstraZeneca AB
Sodertalje SE
Correspondent
Wm. Charles Saunders AstraZeneca Pharmaceuticals LP 1800 Concord Pike OW2 Wilmington, DE 19850
Filing Details
Filing Date:
2003-02-25
Status Date:
2007-06-13
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.